Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Pediatric Mechanical Circulatory Support

  • Wilmot, Ivan (Department of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine) ;
  • Lorts, Angela (Department of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine) ;
  • Morales, David (Department of Congenital Heart Surgery, The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine)
  • Received : 2013.10.29
  • Accepted : 2013.10.29
  • Published : 2013.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Mechanical circulatory support (MCS) in the pediatric heart failure population has a limited history especially for infants, and neonates. It has been increasingly recognized that there is a rapidly expanding population of children diagnosed and living with heart failure. This expanding population has resulted in increasing numbers of children with medically resistant end-stage heart failure. The traditional therapy for these children has been heart transplantation. However, children with heart failure unlike adults do not have symptoms until they present with end-stage heart failure and therefore, cannot safely wait for transplantation. Many of these children were bridged to heart transplantation utilizing extracorporeal membranous oxygenation as a bridge to transplant which has yielded poor results. As such, industry, clinicians, and the government have refocused interest in developing increasing numbers of MCS options for children living with heart failure as a bridge to transplantation and as a chronic therapy. In this review, we discuss MCS options for short and long-term support that are currently available for infants and children with end-stage heart failure.

Keywords

References

  1. Rossano JW, Zafar F, Graves DE, et al. Prevalence of heart failure related hospitalizations and risk factors for mortality in pediatric patients: an analysis of a nationwide sampling of hospital discharges. Circulation 2009;120:S586.
  2. Jeewa A, Manlhiot C, McCrindle BW, Van Arsdell G, Humpl T, Dipchand AI. Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation. Artif Organs 2010; 34:1087-91. https://doi.org/10.1111/j.1525-1594.2009.00969.x
  3. Morales DL, Adachi I, Heinle JS, Fraser CD Jr. A new era: use of an intracorporeal systemic ventricular assist device to support a patient with a failing Fontan circulation. J Thorac Cardiovasc Surg 2011;142:e138-40. https://doi.org/10.1016/j.jtcvs.2011.05.018
  4. Morales DL, Khan MS, Gottlieb EA, Krishnamurthy R, Dreyer WJ, Adachi I. Implantation of total artificial heart in congenital heart disease. Semin Thorac Cardiovasc Surg 2012;24:142-3. https://doi.org/10.1053/j.semtcvs.2012.04.006
  5. Helman DN, Addonizio LJ, Morales DL, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant 2000;19: 121-6. https://doi.org/10.1016/S1053-2498(99)00116-3
  6. Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723-30. https://doi.org/10.1016/S0003-4975(99)00042-9
  7. Davies RR, Russo MJ, Hong KN, et al. The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2008; 135:421-7, 427.e1. https://doi.org/10.1016/j.jtcvs.2007.09.048
  8. Morales DL, Zafar F, Rossano JW, et al. Use of ventricular assist devices in children across the United States: analysis of 7.5 million pediatric hospitalizations. Ann Thorac Surg 2010;90:1313-8. https://doi.org/10.1016/j.athoracsur.2010.04.107
  9. Wilmot I, Morales DL, Price JF, et al. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail 2011;17:487-94. https://doi.org/10.1016/j.cardfail.2011.02.008
  10. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004;351:859-67. https://doi.org/10.1056/NEJMoa040186
  11. Padalino MA, Bottio T, Tarzia V, et al. HeartWare ventricular assist device as bridge to transplant in children and adolescents. Artif Organs 2013 Oct 3 [Epub]. http://dx.doi. org/10.1111/aor.12185.
  12. Miera O, Potapov EV, Redlin M, et al. First experiences with the HeartWare ventricular assist system in children. Ann Thorac Surg 2011;91:1256-60. https://doi.org/10.1016/j.athoracsur.2010.12.013
  13. Fraser CD Jr, Jaquiss RD, Rosenthal DN, et al. Prospective trial of a pediatric ventricular assist device. N Engl J Med 2012;367:532-41. https://doi.org/10.1056/NEJMoa1014164
  14. Cabrera AG, Sundareswaran KS, Samayoa AX, et al. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States. J Heart Lung Transplant 2013;32:1107-13. https://doi.org/10.1016/j.healun.2013.07.012
  15. Reinhartz O, Keith FM, El-Banayosy A, et al. Multicenter experience with the thoratec ventricular assist device in children and adolescents. J Heart Lung Transplant 2001;20:439- 48. https://doi.org/10.1016/S1053-2498(00)00236-9
  16. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous- flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96. https://doi.org/10.1056/NEJMoa067758
  17. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg 2007; 133:1573-80. https://doi.org/10.1016/j.jtcvs.2006.11.050
  18. Almond CS, Morales DL, Blackstone EH, et al. Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 2013; 127:1702-11. https://doi.org/10.1161/CIRCULATIONAHA.112.000685
  19. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51. https://doi.org/10.1056/NEJMoa0909938
  20. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001;122:440-8. https://doi.org/10.1067/mtc.2001.115243
  21. Reiss N, El-Banayosy A, Arusoglu L, Blanz U, Bairaktaris A, Koerfer R. Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist. ASAIO J 2006;52:211-4. https://doi.org/10.1097/01.mat.0000178049.13589.31
  22. Khan MS, Mery CM, Zafar F, et al. Is mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy?: analysis of the United Network of Organ Sharing database. J Heart Lung Transplant 2012;31: 1192-8. https://doi.org/10.1016/j.healun.2012.07.004
  23. Uzark K, King E, Cripe L, et al. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics 2012;130:e1559-66. https://doi.org/10.1542/peds.2012-0858
  24. Young JB. Healing the heart with ventricular assist device therapy: mechanisms of cardiac recovery. Ann Thorac Surg 2001;71(3 Suppl):S210-9. https://doi.org/10.1016/S0003-4975(00)02633-3
  25. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 2001;121:902-8. https://doi.org/10.1067/mtc.2001.112632
  26. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20. https://doi.org/10.1161/01.CIR.91.11.2717
  27. Meliones JN, Custer JR, Snedecor S, Moler FW, O'Rourke PP, Delius RE. Extracorporeal life support for cardiac assist in pediatric patients: review of ELSO Registry data. Circulation 1991;84(5 Suppl):III168-72. https://doi.org/10.1161/01.CIR.84.1.168
  28. Morales DL, Almond CS, Jaquiss RD, et al. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 2011;30:1-8. https://doi.org/10.1016/j.healun.2010.08.033

Cited by

  1. Ventricular assist device use in congenital heart disease with a comparison to heart transplant vol.3, pp.5, 2013, https://doi.org/10.2217/cer.14.42
  2. The Use of Ventricular Assist Device Support in Children: The State of the Art vol.39, pp.1, 2013, https://doi.org/10.1111/aor.12439
  3. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction vol.28, pp.3, 2013, https://doi.org/10.1017/s1047951117002281
  4. Eighteen years of paediatric extracorporeal membrane oxygenation and ventricular assist devices: insight regarding late outcomes vol.28, pp.11, 2013, https://doi.org/10.1017/s1047951118001282
  5. Tipless transseptal cannula concept combines improved hemodynamic properties and risk‐reduced placement: An in silico proof‐of‐concept vol.45, pp.9, 2013, https://doi.org/10.1111/aor.13964